日韩黄色一级片免费看-丁香婷婷激情五月天综合-日日激情综合久久一区-久久麻豆精亚洲av品国产一区

  設(shè)為主頁 加入收藏 English
 
 
 
 新聞動態(tài)
 行業(yè)動態(tài)
 展會信息
 誠聘英才
 
 

測量應(yīng)用案例-20211210

發(fā)布時間:2021-12-08  點擊次數(shù):198  新聞來源:
 

文獻(xiàn)名:In-use interfacial stability of monoclonal antibody formulations diluted in saline iv bags

 

 

 

作者 Aadithya Kannanab, Ian C.Shiehb, Petar Hristova, Gerald G.Fullera

aStanford University, Stanford, CA, USA

bGenentech, Inc., South San Francisco, CA, USA

 

 

摘要:The use of monoclonal antibodies (mAbs) for the treatment of a variety of diseases is rapidly growing each year. Many mAbs are administered intravenously using i.v. bags containing 0.9% NaCl (normal saline). We studied the aggregation propensity of these antibody solutions in saline and compared it with a low ionic strength formulation buffer. The mAb studied in this work is prone to aggregate, and is known to form a viscoelastic network at the air-solution interface. We observed that this interfacial elasticity increased when formulated in saline. In the bulk, the mAbs exhibited a tendency to self-associate that was higher in saline. We also studied the aggregation of the mAbs in the presence of polysorbate-20, typically added to formulations to mitigate interfacial aggregation. We observed that with surfactants, the presence of salt in the buffer led to a greater mAb adsorption at the interface and resulted in the formation of more particulate aggregates. Our results show that the addition of salt to the buffer led to differences in the interfacial aggregation in mAb formulations, showing that stress studies used to screen for mAb aggregation intended for i.v. administration should be performed in conditions representative of their intended route of administration.

 

關(guān)鍵詞:Monoclonal antibody(s); Adsorption; Surfactant(s); Formulation; Protein aggregation; Rheology; Protein formulation(s)

 

 
 
上海市普陀區(qū)嵐皋路567號1108-26室 電話:021-62665073 400-718-7758 傳真:021-62761957
美國布魯克海文儀器公司上海代表處 版權(quán)所有  管理登陸 ICP備案號:滬ICP備19006074號-2 技術(shù)支持:化工儀器網(wǎng)